Based on the measurements of operating efficiency obtained from Scisparc's historical financial statements, Scisparc is not in a good financial situation at this time. It has a very high odds of going through financial crisis in December. At present, Scisparc's Total Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Total Stockholder Equity is expected to grow to about 8 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 387.6 K. Key indicators impacting Scisparc's financial strength include:
The essential information of the day-to-day investment outlook for Scisparc includes many different criteria found on its balance sheet. An individual investor should monitor Scisparc's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Scisparc.
Net Income
(5.38 Million)
Scisparc
Select Account or Indicator
Price To Sales Ratio
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Sales General And Administrative To Revenue
Research And Ddevelopement To Revenue
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Short Term Coverage Ratios
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Cash Conversion Cycle
Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Gross Profit Margin
Price Fair Value
Return On Equity
Change In Cash
Stock Based Compensation
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Cashflows From Financing Activities
Depreciation
Other Non Cash Items
Capital Expenditures
Total Cash From Operating Activities
Change To Account Receivables
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Investments
Net Borrowings
Total Cashflows From Investing Activities
Change To Operating Activities
Other Cashflows From Investing Activities
Change To Netincome
Change To Liabilities
Change To Inventory
Issuance Of Capital Stock
Common Stock Shares Outstanding
Total Assets
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Property Plant And Equipment Net
Net Debt
Retained Earnings
Accounts Payable
Cash
Non Current Assets Total
Other Assets
Cash And Short Term Investments
Net Receivables
Liabilities And Stockholders Equity
Non Current Liabilities Total
Other Current Assets
Other Stockholder Equity
Total Liab
Total Current Assets
Accumulated Other Comprehensive Income
Common Stock
Non Currrent Assets Other
Inventory
Net Tangible Assets
Net Invested Capital
Net Working Capital
Property Plant Equipment
Short Long Term Debt Total
Current Deferred Revenue
Short Long Term Debt
Capital Stock
Short Term Debt
Capital Lease Obligations
Property Plant And Equipment Gross
Depreciation And Amortization
Interest Expense
Selling General Administrative
Other Operating Expenses
Operating Income
Ebit
Research Development
Ebitda
Total Operating Expenses
Income Before Tax
Total Other Income Expense Net
Income Tax Expense
Selling And Marketing Expenses
Gross Profit
Cost Of Revenue
Net Interest Income
Interest Income
Total Revenue
Net Income From Continuing Ops
Reconciled Depreciation
Net Income Applicable To Common Shares
Minority Interest
Tax Provision
Probability Of Bankruptcy
Understanding current and past Scisparc Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Scisparc's financial statements are interrelated, with each one affecting the others. For example, an increase in Scisparc's assets may result in an increase in income on the income statement.
Please note, the presentation of Scisparc's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Scisparc's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Scisparc's management manipulating its earnings.
Scisparc Stock Summary
Scisparc competes with Virax Biolabs, ZyVersa Therapeutics, Unicycive Therapeutics, Quoin Pharmaceuticals, and Cardio Diagnostics. SciSparc Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel. Scisparc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 3 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
Comparative valuation techniques use various fundamental indicators to help in determining Scisparc's current stock value. Our valuation model uses many indicators to compare Scisparc value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Scisparc competition to find correlations between indicators driving Scisparc's intrinsic value. More Info.
Scisparc is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Scisparc's Return On Equity is projected to drop based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Scisparc's earnings, one of the primary drivers of an investment's value.
Scisparc Systematic Risk
Scisparc's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Scisparc volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Scisparc correlated with the market. If Beta is less than 0 Scisparc generally moves in the opposite direction as compared to the market. If Scisparc Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Scisparc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Scisparc is generally in the same direction as the market. If Beta > 1 Scisparc moves generally in the same direction as, but more than the movement of the benchmark.
About Scisparc Financials
What exactly are Scisparc Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Scisparc's income statement, its balance sheet, and the statement of cash flows. Potential Scisparc investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Scisparc investors may use each financial statement separately, they are all related. The changes in Scisparc's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Scisparc's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
Today, most investors in Scisparc Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Scisparc's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Scisparc growth as a starting point in their analysis.
Price Earnings To Growth Ratio
0.17
At present, Scisparc's Price Earnings To Growth Ratio is projected to increase significantly based on the last few years of reporting.
Scisparc November 26, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Scisparc help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Scisparc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Scisparc based on widely used predictive technical indicators. In general, we focus on analyzing Scisparc Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Scisparc's daily price indicators and compare them against related drivers.
When running Scisparc's price analysis, check to measure Scisparc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scisparc is operating at the current time. Most of Scisparc's value examination focuses on studying past and present price action to predict the probability of Scisparc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scisparc's price. Additionally, you may evaluate how the addition of Scisparc to your portfolios can decrease your overall portfolio volatility.